Medtronic earns FDA approval for insertable cardiac monitor

Medtronic received market clearance from the Food and Drug Administration for its insertable cardiac monitor.

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient's chest during a minimally invasive procedure. The implanted device allows clinicians to continuously monitor a patient's heartbeat for up to three years, according to a company news release.

The device uses wireless communication to upload device data, and patients can undergo MRIs while using the implanted device.

More articles on supply chain:

Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
7 things to know about Dr. Scott Gottlieb's relationship with the drug industry
Mylan settles biosimilar patent dispute with Roche: 4 things to know


Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars